文献速递白血病

成人急性髓系白血病中PTPN11突变的临床影响

The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia.
PubMed 文献 · Leukemia · 2020-06-19

研究对1406例在本机构治疗的成人急性髓系白血病患者进行靶向二代测序,112例(8%)存在PTPN11突变。PTPN11突变与较低的完全缓解率(54% vs 40%;P=0.04)和较短的总生存期(中位13.6 vs 8.4个月;P=0.008)相关,多因素分析显示PTPN11突变独立增加死亡风险(HR 1.69;95%CI 1.25-2.29;P=0.0007)。

要点

  • 成人AML中PTPN11突变率为8%(112/1406)。
  • PTPN11突变与急性粒单核细胞/单核细胞白血病亚型相关,在核心结合因子AML中未检测到。
  • PTPN11突变与较低完全缓解率(54% vs 40%)和较短总生存期(中位13.6 vs 8.4个月)相关。

核心结论

  • PTPN11突变在成人AML中具有特征性表型,并与不良预后相关。

研究设计与样本

  • 研究为在本机构治疗的成人AML患者中进行的靶向二代测序筛查,共纳入1406例连续患者。

主要发现

  • 112例(8%)患者存在PTPN11突变。
  • PTPN11突变较野生型更常见于急性粒单核细胞/单核细胞白血病亚型,而在核心结合因子AML患者中未检测到。
  • PTPN11突变与NPM1突变和FLT3内部串联重复共现更常见,与IDH2突变和复杂核型共现较少见。
  • 与野生型等位基因相比,PTPN11突变与较低的完全缓解率相关(54% vs 40%;P=0.04)。
  • 与野生型等位基因相比,PTPN11突变与较短的总生存期相关(中位13.6 vs 8.4个月;P=0.008)。

关键数值与推荐

  • 多因素分析中,PTPN11突变独立增加死亡风险,风险比(HR)为1.69(95%CI 1.25-2.29;P=0.0007)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While germline and somatic mutations in the gene PTPN11, encoding a phosphatase which regulates the RAS signaling pathway, are well characterized in children with Noonan syndrome and juvenile myelomonocytic leukemia, less is known about their clinical impact in adults with acute myeloid leukemia (AML). To elucidate the effect of PTPN11 mutations (PTPN11mut) on clinical outcomes, we screened adult patients with AML treated at our institution using targeted next-generation sequencing. Among 1406 consecutive patients, 112 (8%) had PTPN11mut. These mutations were more commonly associated with the acute myelomonocytic/monocytic leukemia subtype than was wild-type PTPN11, while none were detected in patients with core-binding factor AML. They co-occurred more commonly with NPM1 mutations and FLT3 internal tandem duplications and less commonly with mutations in IDH2 and a complex karyotype. Compared with the wild-type allele, PTPN11mut was associated with lower complete response rates (54% vs 40%; P = 0.04), and shorter overall survival (median 13.6 vs 8.4 months; P = 0.008). In a multivariate analysis, PTPN11mut independently increased the risk of death, with a hazard ratio of 1.69 (95% CI, 1.25-2.29; P = 0.0007). In summary, mutations in PTPN11 have a characteristic phenotype in adults with AML and are associated with an adverse prognosis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Alfayez M, Issa GC, Patel KP, et al. The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia. Leukemia. 2020. PMID: 32561839. doi:10.1038/s41375-020-0920-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。